Overview

Effect of Papaverine on Renal Artery Blood Flow Volume

Status:
Completed
Trial end date:
2021-04-15
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the effect of papaverine on renal artery blood flow after declamping of renal artery.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Asan Medical Center
Treatments:
Papaverine
Criteria
Inclusion Criteria:

- Patients diagnosed with kidney cancer.

- Patients undergoing robot assisted partial nephrectomy under general anesthesia

- 20 years old ≤ age <80 years old

- Patients who voluntarily agreed to this clinical study

- eGFR ≥ 60 ml / min / 1.73 m2 (Chronic Kidney Disease Epidemiology Patients with
Collaboration)

Exclusion Criteria:

- The tumor ≥ 7 cm in size

- Multiple renal mass

- If the surgery plan is changed due to open

- When surgery is performed together with other surgery

- Multiple renal artery

- Patients with hypersensitivity to papaverine

- Patients with atrioventricular block

- Pregnant and lactating women

- Patients using levodopa

- Refusal of patient